Biomedical Research

Journal Banner

Clinical effect of two-ports thoracoscopic pulmonary lobectomy and systemic lymphadenectomy for bronchogenic carcinoma

Objective: To investigate clinical effect of two-ports thoracoscopic pulmonary lobectomy and systemic lymphadenectomy in curing bronchogenic carcinoma well.

Background: Single-port and multiple-ports thoracoscopic surgery treating lung cancer were reported more. Each of them has their own advantages and disadvantages, and now two-ports thoracoscopic surgery treating lung cancer is more widely used.

Methods: A quantity of 124 patients with bronchogenic carcinoma involved in our hospital from August 2014 to June 2016 were randomly divided into two groups, two-ports VATS group and thoracotomy group (respectively 62 cases) on the basis of the method of random number table. The operative time, blood loss in operation, thoracic drainage, postoperative hospital stay and intraoperative lymph nodes dissection and operation complications were contrasted between both of two-ports VATS group and thoracotomy group.

Results: The operation time of two-ports VATS group was significantly higher than that of thoracotomy group (P<0.05). The intraoperative blood loss, thoracic drainage and hospital stay of two-ports VATS group were distinctly lower than those of thoracotomy group<0.05). There was no obvious difference in the number of intraoperative lymphadenectomy between the two groups (P>0.05). The complication rate of two-ports VATS group was significantly lower than that of thoracotomy group (P<0.05).

Conclusion: Two-ports thoracoscopic pulmonary lobectomy and systemic lymphadenectomy are a secure and effective method for the treatment of lung cancer. It is worthy of popularization and application.

Author(s): Shimeng Wang, Lin Li, Qi Liu, Guo-Dong Gao